Longitudinal Morphological and Physiological Monitoring of Three-dimensional Tumor Spheroids Using Optical Coherence Tomography
February 9th, 2019
7.3K views
Optical coherence tomography (OCT), a three-dimensional imaging technology, was used to monitor and characterize the growth kinetics of multicellular tumor spheroids. Precise volumetric quantification of tumor spheroids using a voxel counting approach, and label-free dead tissue detection in the spheroids based on intrinsic optical attenuation contrast, were demonstrated.
Overview
This study utilizes optical coherence tomography (OCT) to monitor and characterize the growth kinetics of multicellular tumor spheroids. The technique allows for precise volumetric quantification and label-free detection of dead tissue within the spheroids.
Key Study Components
Area of Science
- Neuroscience
- Oncology
- Imaging Technology
Background
- Three-dimensional tumor spheroids replicate in vivo tumor properties.
- They provide more clinically relevant data for drug discovery compared to 2D cultures.
- OCT can visualize the 3D structure of tumors quickly and accurately.
- Proper experimental setup is crucial for forming tumor spheroids.
Purpose of Study
- To enhance the understanding of tumor growth kinetics.
- To improve drug discovery timelines and reduce costs.
- To utilize 3D imaging for better characterization of tumor morphology.
Methods Used
- Optical coherence tomography (OCT) for imaging.
- Voxel counting approach for volumetric quantification.
- Label-free detection of dead tissue based on optical attenuation.
- Use of ultra-low attachment plates for spheroid formation.
Main Results
- Successful monitoring of tumor spheroid growth kinetics.
- Demonstrated accurate volumetric quantification.
- Effective detection of dead tissue within spheroids.
- Potential to shorten drug discovery timelines.
Conclusions
- OCT is a valuable tool for studying tumor spheroids.
- It provides insights that can enhance drug development processes.
- Further optimization of spheroid formation techniques is necessary.
Frequently Asked Questions
What is optical coherence tomography?
Optical coherence tomography (OCT) is a non-invasive imaging technique that provides high-resolution, three-dimensional images of biological tissues.
How do tumor spheroids differ from 2D cultures?
Tumor spheroids better mimic the in vivo environment of tumors, allowing for more accurate studies of tumor behavior and drug responses.
What are the advantages of using OCT in this research?
OCT allows for rapid imaging and characterization of tumor spheroids without the need for labeling, providing real-time insights into their growth and structure.
What is the significance of dead tissue detection?
Detecting dead tissue within tumor spheroids can help assess the effectiveness of anti-cancer treatments and improve therapeutic strategies.
How can this research impact drug discovery?
By providing more relevant data on tumor behavior, this research can help streamline the drug discovery process, making it faster and more cost-effective.
Executive Industry Relevance
High-throughput optical coherence tomography (HT-OCT) enables label-free, non-destructive 3D imaging of tumor spheroids in multi-well plates, addressing a key limitation in cancer drug discovery where conventional modalities fail to resolve full 3D structure due to poor penetration and depth resolution. By providing longitudinal morphological and physiological data—including size, volume, and necrotic region growth—HT-OCT supports mechanistic de-risking and predictive confidence in target validation and lead identification workflows. This capability positions HT-OCT as a translational tool for screening anti-cancer compounds in physiologically relevant 3D models, improving the fidelity of preclinical decision-making.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by monitoring longitudinal growth and structural integrity of tumor spheroids under compound treatment.
- Operational Value: Provides quantitative, label-free readouts of spheroid morphology and viability without exogenous markers, reducing assay complexity.
- Predictive Value: Supports biological de-risking through direct visualization of necrotic core development, a hallmark of tumor microenvironment evolution.
Screening & Assay Development
- Scientific Value: Generates 3D structural and attenuation-based contrast data enabling discrimination between viable and necrotic regions in spheroids.
- Operational Value: Integrates with 96-well plate formats for automated, whole-plate scanning, enhancing throughput and reproducibility in screening campaigns.
- Assay Readiness: Produces orthogonal slices and 3D renderings that standardize morphological assessment across wells and timepoints.
Translational & Preclinical Research
- Translational Continuity: Maintains physiological relevance by monitoring spheroid growth kinetics and structural changes over 21 days, mirroring in vivo tumor evolution.
- Mechanistic De-risking: Tracks intrinsic optical attenuation to quantify dead-cell regions, offering a label-free surrogate for histopathological assessment.
- Preclinical Alignment: Supports risk-adjusted advancement decisions by linking morphological changes to functional outcomes in tumor models.
Pipeline & Workflow Integration
HT-OCT fits within the discovery continuum from early target validation through lead identification to preclinical evaluation, offering a bridge between 2D screening and complex in vivo models by delivering 3D phenotypic data in a scalable format.
- Discovery Biology: Supports hypothesis testing via longitudinal monitoring of spheroid size, height, and volume, enabling dynamic assessment of compound effects on tumor growth.
- Screening: Delivers assay-ready 3D OCT data with consistent focal plane alignment across wells, ensuring reproducible imaging for comparative compound screening.
- Analytics: Provides voxel-based volumetric quantification and attenuation contrast metrics that enable objective comparison of spheroid morphology and necrotic burden.
- Translational Research: Connects to preclinical continuity by modeling structural degeneration and necrotic progression observed in avascular tumor growth.
- Enterprise Reuse: Establishes a reusable imaging platform applicable to diverse 3D models including co-cultures and biofabricated tissues beyond oncology.
Operational & Enterprise Impact
- Scientific Value: Enhances predictive confidence by reducing mechanistic ambiguity in tumor response assessment through direct 3D structural and viability tracking.
- Operational Value: Ensures standardization and reproducibility via automated plate scanning and invariant well positioning, minimizing technical variance.
- Strategic Value: Improves go/no-go decisions by delivering early, physiologically relevant signals of compound efficacy or toxicity in 3D context.
- Portfolio Impact: Enables risk-adjusted prioritization by identifying compounds that modulate spheroid growth or necrotic fraction, informing lead optimization.
Implementation Considerations
- Requires expertise in optical system alignment, including spectrometer construction and stage calibration for multi-well plate imaging.
- Depends on stable OCT hardware with translation, tilt, and rotation stages to maintain focal consistency across 96-well formats.
- Necessitates cross-team standardization of spheroid formation protocols, particularly ultra-low attachment plate use and centrifugation parameters.
- Involves adaptation of image processing pipelines for 3D rendering, orthogonal slicing, and voxel-based analysis across varying spheroid sizes.
- Limited by spheroid height (~600 µm) and imaging depth, constraining applicability to models within OCT’s penetration range.
Biopharma FAQs
Why does longitudinal size and volume tracking matter for target validation in 3D tumor models?
Longitudinal monitoring of tumor spheroid diameter, height, and voxel-based volume enables quantification of growth kinetics and structural changes over time, providing a dynamic readout for assessing target modulation in 3D culture. This supports mechanistic de-risking by linking compound effects to phenotypic outcomes in a physiologically relevant model.
How does intrinsic optical attenuation contrast enable detection of dead-cell regions in tumor spheroids?
Optical coherence tomography detects necrotic areas through label-free intrinsic attenuation contrast, where increased light scattering and absorption in dead-cell regions produce measurable signal changes. This allows longitudinal tracking of necrotic core development from day 7 to day 14 without exogenous labels or fixation.
What quantitative outputs from 3D OCT data support reproducible screening campaigns?
HT-OCT generates 3D structural images, orthogonal XY, XZ, and YZ slices, and voxel-based volume measurements that provide standardized, quantitative morphometric readouts across wells and timepoints. These outputs enable objective comparison of spheroid growth and structural integrity in high-throughput formats.
Why are replication and plate stabilization requirements critical for cross-functional HT-OCT implementation?
Correction of plate tilting and rotation using 2D stages ensures consistent focal plane and well positioning across the 96-well plate, minimizing imaging variability. This standardization is essential for reliable data generation across biology, assay development, and analytics teams.
What statistical analysis capabilities are needed to interpret HT-OCT-derived growth and necrosis metrics?
Analysis of longitudinal growth curves and necrotic region progression requires statistical comparison of size, volume, and attenuation contrast across treatment groups and timepoints. These capabilities support evaluation of significant differences in tumor spheroid morphology and viability for decision-making in lead identification.
